Eton Pharmaceuticals, Inc. (ETON)
57.69
-1.80
(-3.03%)
USD |
NASDAQ |
Sep 25, 16:00
57.69
0.00 (0.00%)
After-Hours: 19:59
Eton Pharmaceuticals Research and Development Expense (Annual) : 7.765M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 7.765M |
| December 31, 2024 | 3.255M |
| December 31, 2023 | 3.322M |
| December 31, 2022 | 3.996M |
| December 31, 2021 | 6.235M |
| Date | Value |
|---|---|
| December 31, 2020 | 14.10M |
| December 31, 2019 | 11.56M |
| December 31, 2018 | 5.627M |
| December 31, 2017 | 3.93M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Nektar Therapeutics | 117.07M |
| Pfizer Inc. | 10.25B |
| Elite Pharmaceuticals, Inc. | 5.743M |
| Daré Bioscience, Inc. | 3.889M |
| Liquidia Corp. | 38.45M |